language-icon Old Web
English
Sign In
Acemap > Paper > Denosumab (AMG 162) Inhibition of Rank Ligand Increases Bone Mineral Density After Two Years of Treatment in Postmenopausal Women with Low Bone Mineral Density

Denosumab (AMG 162) Inhibition of Rank Ligand Increases Bone Mineral Density After Two Years of Treatment in Postmenopausal Women with Low Bone Mineral Density

2006 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    4
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.